These findings are in contrast with the study of Marquie et al. [19], in which no detectable [18F]AV1451 binding was demonstrated in cryosections containing FTLD-tau lesions from PiD (and other tauopathies: PSP and CBD) when the signal was contrasted to that of control brains. The gene discussed is MAPT; the disease is red-green color blindness.